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Abstract
In mammalian cells, de novo glycerolipid synthesis begins with the acylation of glycerol-
3-phosphate, catalyzed by glycerol-3-phosphate acyltransferases (GPAT). GPAT2 is a
mitochondrial isoform primarily expressed in testis under physiological conditions, and
overexpressed in several types of cancers and cancer-derived human cell lines where its
expression contributes to the tumor phenotype. Using gene silencing and atomic force
microscopy, we studied the correlation between GPAT2 expression and cell surface
topography, roughness and membrane permeability in MDA-MB-231 cells. In addition,
we analyzed the glycerolipid composition by gas-liquid chromatography. GPAT2 expres-
sion altered the arachidonic acid content in glycerolipids, and the lack of GPAT2 seems
to be partially compensated by the overexpression of another arachidonic-acid-metabo-
lizing enzyme, AGPAT11. GPAT2 expressing cells exhibited a rougher topography and
less membrane damage than GPAT2 silenced cells. Pore-like structures were present
only in GPAT2 subexpressing cells, correlating with higher membrane damage evidenced
by lactate dehydrogenase release. These GPAT2-induced changes are consistent with
its proposed function as a tumor-promoting gene, and might be used as a phenotypic dif-
ferentiation marker. AFM provides the basis for the identification and quantification of
those changes, and demonstrates the utility of this technique in the study of cancer cell
biology.
Introduction
Glycerol-3-phosphate acyltransferase (GPAT) catalyzes the first and committed step in the de
novo glycerolipid synthesis pathway, which is the synthesis of lysophosphatidic acid (LPA) via
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the acylation of glycerol 3-phosphate by a long-chain fatty acyl-CoA substrate. Then, 1-acylgly-
cerol-3-phosphate acyltransferase (AGPAT) uses LPA to form phosphatidic acid, the precursor
for both triacylglycerol (TAG) and glycerophospholipid (PL) biosynthesis. In mammals, four
GPAT isoforms (GPAT1–GPAT4) have been described which differ in their subcellular loca-
tions, tissue expression pattern, substrate preference, transcriptional regulation and sensitivity
to sulfhydryl group reagents such as N-ethylmaleimide [1].
In physiological conditions, GPAT2 isoform resides in the outer mitochondrial membrane
of primary spermatocytes and it is differentially expressed in the testis during sexual develop-
ment [2,3]. GPAT2’s preferred substrate is arachidonoyl-CoA and this fatty acid (FA) is used
to synthesize TAG de novo [2]. Because high levels of arachidonic acid (Δ5,8,11,14 eicosatetrae-
noic acid, 20:4 ω-6, AA) induce apoptosis [4–6], and metabolic pathways that diminish the
content of unesterified AA can prevent apoptosis [7], enhanced GPAT2 activity may allow
spermatogenic cells to sequester AA into TAG, a function that may be related to cell survival
and proliferation [2,3].
In pathological conditions, we have reported that human GPAT2 is overexpressed in sev-
eral types of cancers and cancer-derived human cell lines, and that its expression contributes
to the tumor phenotype. In this regard, tumor cells with diminished GPAT2 expression had
lower rates of cellular proliferation and migration and lower tumorigenicity in mouse xeno-
graft models. In addition, we have shown that GPAT2 belongs to a group of genes termed
‘cancer-testis genes’ (CTs) [8]. Proteins encoded by CTs are expressed in spermatogenic cells,
whereas in somatic tissues their expression is either low or null. CTs are ectopically overex-
pressed in cancers of different origins where they may contribute to the tumor phenotype
[9,10].
Cancer cells differ from normal cells in morphology, cell growth and migration rate, cell–
cell interaction, cytoskeleton organization, and interactions with the extracellular matrix.
Atomic force microscopy (AFM) is capable of detecting most of these changes [11]. AFM is
used to scan surfaces at the nanometer (molecular) resolution scale, and it has emerged as a
powerful tool to study the morphological and biomechanical properties of biological samples,
including biomolecules and cells. This technique is appropriate for directly studying biological
materials in buffer solutions or in fixed conditions. It allows sample observation in non-vacu-
ous environments, without the need for coating, staining or freezing the material, and the
resolution is similar to electron microscopy [12,13]. During the last few years, AFM has been
increasingly used in biomedical research. It has been applied for the nanomechanical study of
live cancer cells isolated from human metastatic fluids [14,15] and breast cancer tissue sections
from different histological grades [16].
In this work, we used AFM to evaluate the phenotypic consequence of GPAT2 expression
in cancer cells, and to correlate human GPAT2 expression with the cellular processes that exac-
erbate the tumoral phenotype in a breast cancer cell model.
Materials and methods
All chemicals were purchased from Sigma unless otherwise indicated.
Cell line and culture conditions
Human breast adenocarcinoma MDA-MB-231 cells were purchased from the American Type
Culture Collection (ATCC, Manassas, VA, USA). Cells were routinely cultured in Dulbecco’s
modified Eagle’s medium (DMEM, Gibco) supplemented with 10% FBS (Natocor, Argentina),
100 U/ml penicillin, 100 μg/ml streptomycin and 2 mM glutamine. Cells were grown at 37˚C
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in a 5% CO2 atmosphere with 98% relative humidity. We chose the MDA-MB-231 cells
because of its high GPAT2 expression.
MDA-MB-231 GPAT2 silencing
Cell lines stably expressing a small-hairpin RNA targeting GPAT2 mRNA (shRNA-GPAT2) or
a non-silencing scrambled RNA (shRNA-scr) were developed in our laboratory from commer-
cial MDA-MB-231 cells, as previously reported [8] to generate sh-MDA (reduced GPAT2
expression) and scr-MDA (retaining GPAT2 expression) cell lines. GPAT2 knockdown was
routinely assessed by quantitative real-time PCR (qRT-PCR) [8] and Western blot.
Quantitative real-time PCR
Total RNA was isolated from cell lines using TRIZOL (Life Technologies) following the manu-
facturer’s instructions, and RNA quality was determined by gel electrophoresis and 260/230
and 260/280 nm absorbance ratios. One μg RNA was used for cDNA synthesis employing
iScript cDNA synthesis Kit (Bio-Rad). A 1:10 cDNA dilution was used for the qRT-PCR reac-
tion with iTaq Universal Sybr Green Super Mix (Bio-Rad). Primers were designed to amplify:
Human GPAT2
forward primer: AAG CTG GTG TGA GGT GAG AG
reverse primer: ATA CTT CCC CAG GAA TGG AG
AGPAT11/LPCAT2
forward primer: ATA GCC CAA GGG GAC TCA AT
reverse primer: GAA AAC ACA TGG CAC GTC TG
MBOAT5/LPCAT3
forward primer: GCG GCT GAT CAT CTC CAT CTT
reverse primer: TGG TAG AGC TGG TTT CCA AAG
MBOAT7/LPIAT1
forward primer: CTC AGC TCT CCG TTC TCG AC
reverse primer: GAA CAG ACG GGC TCT GGA AA
The thermal profile was 95˚C for 1 min, followed by 45 cycles of 95˚C for 20 s, 57˚C for 50 s
and 60˚C for 30 s, on a Stratagene Mx3000P apparatus. RNA expression was quantified in trip-
licate using the ΔΔCt method, and normalized to that of TBP housekeeping gene using Qbase
software.
Immunoblotting
One-hundred μg of total protein from cells was separated on 10% SDS-PAGE, transferred to a
polyvinylidene difluoride membrane (BioRad) and probed with 1/1000 anti-GPAT2 antibody
(Sigma HPA036841). Anti-β-actin antibody (Abcam ab8227) at a dilution 1:2500 was used as a
gel-loading control. Membranes were then washed extensively and probed with horseradish
peroxidase-conjugated goat anti- rabbit or anti- mouse IgG antibody (Thermo-Pierce). For
chemiluminescent detection, the membranes were incubated with Super Signal detection kit
(Thermo-Pierce).
Lipid and fatty acid analysis
scr-MDA and sh-MDA cells were grown in 100 mm plates in routine medium or in routine
medium supplemented with 50 μM AA as the sodium salt (Sigma) for 72 h. Cells were then
washed 3 times with 0.1% BSA in ice-cold PBS, and scraped in ice-cold methanol and H2O.
Total lipids were extracted [17] and separated by TLC on silica-gel G60 plates (Merck) with
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hexane-ethylether-acetic acid (80:20:1; v/v/v) as the mobile phase for neutral lipid separation.
All samples were chromatographed in parallel with pure lipid standards. To analyze the FA
composition, total PL and TAG fractions were scraped from the plate and eluted with hexane:
chloroform: methanol (3:2:1, v/v/v). FA methyl esters were obtained by reaction with BF3 in
methanol and analyzed by gas liquid chromatography in a Hewlett-Packard HP 6890 chro-
matograph equipped with an Omega Wax capillary column [2].
Optical and fluorescence microscopy
Live cell images were captured with an inverted microscope (Olympus, IX71) equipped with a
fluorescent lamp and a digital camera (Olympus) under 200-x magnification.
Atomic force microscopy
For Atomic force microscopy (AFM) measurements, scr-MDA (control) and sh-MDA
(GPAT2 silenced) cells were plated on glass coverslips and grown in routine medium without
the addition of AA for 1−2 days until 80% confluent. Then, the cells were fixed using an etha-
nol dehydration train at room temperature and subsequently air dried [18]. Fixation is neces-
sary because high-resolution images of cells are poorly achieved in solution, and the enhanced
AFM resolution obtained with fixed cells allows a more detailed subcellular analysis [12].
AFM images were obtained in air, using a MultiMode Scanning Probe Microscope (Veeco)
equipped with a Nanoscope V controller (Veeco). All measurements were obtained immedi-
ately after fixation with Tapping1 mode, using probes doped with silicon nitride (RTESP,
Veeco with tip nominal radius of 8–12 nm, 271–311 kHz, force constant 20–80 N/m). Typical
scan rates were 0.5 Hz.
The analysis was first performed on a large area (50 μm2) with a single cell, and later by
heading the cantilever to the cell surface to obtain images of 30 μm2, 15 μm2, and 10 μm2.
The same procedure was repeated in six different cells (three cells each time in two indepen-
dent AFM measurements), with three different AFM acquisition modes: height, phase, and
amplitude.
Roughness analysis
The effect of GPAT2 silencing on membrane roughness of MDA-MB-231 cells was determined
using AFM and taking into consideration the Ra and Rq values as quantitative parameters.
The parameter Ra is the arithmetic mean of the deviations in height from the roughness mean
value, and Rq is the root mean square of the height distribution. In the current bibliography,
the minimum number of cells necessary to perform roughness studies is not standardized.
Thus, some authors analyze three [19], four [16] or more cells. Here, for the analysis, six differ-
ent cells from each group were examined and four different areas from each cell were used to
calculate the Ra and Rq. The selected areas were 5 x 5 μm2. They were above the cytoplasmic
region, and outside of the pore zone for sh-MDA cells, on images of 15 x 15 μm2. AFM image
and data analysis was performed using the Nanoscope 7.30 and Nanoscope Analys 1.5 software
package.
Lactate dehydrogenase activity
To evaluate plasma membrane integrity, cells were grown in a 48-well microplate, and a com-
mercial kit by the decrease of OD at 340 nm (Wiener lab) was used to measure the release of
the cytoplasmic enzyme lactate dehydrogenase (LDH).
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Statistical analysis
Differences between the control and silenced cells were analyzed by Student’s t-test or ANO-
VA-Tukey test. Results were considered significant at the 5% level. Statistical comparisons
were performed with InStat3 software.
Results and discussion
MDA-MB-231 cells compensate for the lack of GPAT2 by
overexpressing the acyltransferase AGPAT11
We used RNA interference to knock-down GPAT2 expression in MDA-MB-231 cells and
obtained 2 stable cell lines: sh-MDA and its control, scr-MDA. Compared to scr-MDA cells, a
95% down-regulation of GPAT2 mRNA was obtained in sh-MDA cells [8]. In this work, the
GPAT2 knockdown was confirmed by Western blot, using an antibody against GPAT2 (Fig
1A and 1B).
Previously, we reported that GPAT2 specifically uses AA as a substrate [2]. For the present
study, our aim was to determine the role of the human GPAT2 isoform in glycerolipid metabo-
lism and plasma membrane functionality in a cancer cell model.
To do this, we isolated the PL and TAG fractions from scr-MDA and sh-MDA cells grown
in routine medium and analyzed the FA compositions (Fig 2A and 2B). Surprisingly, no signif-
icant differences were observed in the AA content of TAG and PL in either cell line. Because
the concentration of AA in the media was low and to expose the cells to a higher amount of
AA, we analyzed the FA composition of PL and TAG fractions of cells, grown for 3 days in
DMEM plus 50 μM AA (Fig 2C and 2D). We chose this AA concentration because incubation
of MDA-MB-231 cells with 200 μM AA for 72 h does not affect cell viability [20], but sh-MDA
cells were more vulnerable and died when exposed to 100μM AA. In the presence of 50 μM
AA for 3 days, sh-MDA cells incorporated more than twice as much AA than scr-MDA cells
in both PL (17.2 vs 8.9%; p< 0.01) and TAG (19.0 vs 5.1%; p< 0.01). The 22:5n6 product of
AA was similarly increased in glycerolipids in the supplemented cells.
AA is an essential FA that is obtained directly from the diet, or indirectly synthesized from
linoleic acid. AA plays important roles in cell metabolism. The bulk of AA in mammalian cells is
rapidly incorporated into cell membrane phospholipids. In addition to its use as a substrate for
glycerolipid synthesis, free AA may exert signaling functions as an inducer of apoptosis or as an
eicosanoid precursor. Because eicosanoids exert potent biological actions, cells keep AA at very
low levels by promoting their esterification into cell lipids [21]. Taking into account the biologi-
cal importance of AA, we suspected that to compensate the lack of GPAT2, sh-MDA cells might
overexpress other enzymes capable of incorporating AA into glycerolipids. To test this hypothe-
sis we measured the expression of other three enzymes involved in the glycerolipid metabolism:
AGPAT11/LPCAT2, MBOAT5/LPCAT3 and MBOAT7/LPIAT1. These three enzymes are able
to use arachidonoyl-CoA as a substrate [21–24]. 1-acyl-glycerol-3-phosphate O-acyltransferase
(AGPAT) and membrane bound O-acyltransferase (MBOAT) are two families of lipid acyltrans-
ferases. The MBOAT family is comprised of members specifically involved in the Lands cycle of
phospholipid FA remodeling, whereas members of the AGPAT family are typically involved in
the pathway of de novo glycerolipid biosynthesis. qRT-PCR analysis showed that compared to
scr-MDA cells, AGPAT11 expression in sh-MDA cells was 2-fold higher. The expression levels
of MBOAT5 and MBOAT7 were equivalent in both cell lines (Fig 3).
GPAT2 specifically uses AA as a substrate [2], and GPAT2 silencing increased the expres-
sion of another glycerolipid biosynthetic enzyme that prefers AA, AGPAT11 (Fig 3).
AGPAT11 uses arachidonoyl-CoA as a substrate for both its 1-acylglycerol-3-phosphate-O-
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acyltransferase and lysophosphatidylcholine acyltransferase activities [24]. Because GPAT iso-
forms catalyze the first and rate-limiting step in de novo glycerolipid biosynthesis, we propose
that AGPAT11 overexpression compensated for the decrease of GPAT2 and may be partially
responsible for the higher AA content of the glycerolipids after GPAT2 silencing. AA incorpo-
ration into glycerolipids depends on its concentration (high or low affinity pathways), the cell
type, and the activity of many different enzymes [21], so we cannot exclude the possibility that
other enzymes may be also be important in determining the overall composition of the cell gly-
cerolipids in both culture conditions.
Cells with deficient GPAT2 exhibit smoother topography and pore-like
structures
The plasma membrane is involved in several cellular functions, including proliferation, signal
transduction, motility, and differentiation. Because GPAT2 silencing alters cell proliferation
Fig 1. GPAT2 knock-down in MDA-MB-231 cells. MDA-MB-231 cells were silenced for human GPAT2 with HuSH-29 plasmid coding for a
shRNA against human GPAT2 mRNA (sh-MDA). A non-effective scrambled sequence shRNA plasmid was used to create a negative
control (scr-MDA). A) Protein expression was measured by Western blot. Total cell lysate (100 μg protein) from scr-MDA and sh-MDA cells
was probed with anti-GPAT2 antibody and with anti-β-actin antibody as a loading control. B) Protein band intensities were quantified with the
ImageJ program. Results are representative of three independent experiments (** p< 0.01). C) Fluorescence image showing GFP
expression in scr-MDA and sh-MDA at 200x magnification confirm that cells were transfected.
https://doi.org/10.1371/journal.pone.0189031.g001
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and migration [8], we decided to study the topography and plasma membrane functionality in
our cell model. For this, we used AFM technique. AFM provides a tri-dimensional mapping
of the cell surface, resulting in the generation of true topographic data with vertical resolution
into the subnanometer range. To minimize the tip impact onto the cell surface we used a
dynamic or intermittent contact mode, commonly known as Tapping mode. Tapping mode is
characterized for the rapid up-and-down oscillation of the tip, which slowly scans the sample
laterally and touches the surface for very short periods of time [13]. Because AFM images may
be affected by the geometrical shape of the probe [25,26], and to minimize the artifacts in cell
Fig 2. Fatty acid composition of scr-MDA and sh-MDA cell PL and TAG. Total lipids were extracted from scr-MDA and sh-MDA cells, separated by
TLC, and fatty acid composition of the PL and TAG fractions was determined by GLC. A and B) Cells grown in DMEM 10% FBS. C and D) Cells grown
in DMEM 10% FBS plus 50 μM of AA for 3 days. Values represent the mean ± SD of 3 independent experiments (* p<0.05, ** p< 0.01).
https://doi.org/10.1371/journal.pone.0189031.g002
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imaging and mechanical measurements, conventional AFM pyramidal tips are routinely used
[27]; so we used pyramidal tips for all our measurements.
Since AFM is a novel tool to observe biological samples, one of its difficulties is the lack of
optimized protocols, mainly for the pre-analytical phase of sample preparation, which makes it
difficult to compare results between laboratories. In this sense, it have been reported that the
Fig 3. mRNA expression of acyltransferases involved in arachidonic acid metabolism. Total RNA from
scr-MDA and sh-MDA cells was extracted, subjected to cDNA synthesis, and amplified by qRT-PCR with
primers for human GPAT2, AGPAT11, MBOAT5 and MBOAT7 genes and normalizing expression levels to that
of TATA-Box binding protein (TBP) housekeeping gene (*** p<0.001. ANOVA-Tukey test).
https://doi.org/10.1371/journal.pone.0189031.g003
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measurements of roughness and viscoelasticity, as well as the cell morphology, are affected
depending on the fixation method, suggesting the necessity of an standard fixation method,
applicable to various cell types [28,29]. Also, the fixation procedure may introduce artifacts
such as cell debris, crystals (commonly derived from the washing buffer, PBS) or depressions
[30]. In addition, for many of the commercially available cell lines there are no previous data
of AFM topography studies. Fortunately, the structure of MDA-MB-231 cells has previously
been elucidated using AFM [31], so we decided to use the same fixation conditions. This fixa-
tion method preserves the epithelial morphology of MDA-MB-231 cells, and during the acqui-
sition of our images, we did not detect any of the most common fixation artifacts reported in
the bibliography [30].
Surface nanostructure imaging (Cell topography). To determine the phenotypic differ-
ences between GPAT2 expressing and silenced cells we analyzed two types of images from
AFM: topography and amplitude images (Fig 4). Topography images show the contour heights,
while amplitude images show how the tip deflected as it encountered simple topography.
Direct comparison of scr-MDA and sh-MDA cells (Fig 4C and 4D (scr-MDA) and Fig 4I
and 4J (sh-MDA)) revealed marked differences in surface morphology at micro- and nano-
scale. The most notable was the presence of pore-like structures in the sh-MDA cells (white
arrow, Fig 4I and 4J).
Comparing optical microscopy (Fig 4F and 4L) with AFM (Fig 4A and 4G) images, we
observe that the fixed cell morphology is consistent with that of live cells.
Cell surface imaging was earlier considered as an important biological application of the
scanning probe microscopy and, more particularly, of the AFM. Thus, these observations dem-
onstrate the uniqueness of AFM for detecting micro- to nanoscale differences for the morpho-
logical characterization of mammalian cell surfaces.
Roughness. The topography images also provided information about the details of the cell
surface structure and its smoothness or roughness. Because roughness value depends on the
size of the sampling field, we analyzed all images in areas of a fixed size of 5 × 5 μm2 [23],
above the cytoplasmic region, on topography images of 15 x 15 μm2; and we determine that Ra
and Rq, measures of surface roughness, both decreased significantly in sh-MDA cells. Com-
paring the Rq values, GPAT2 silencing decreased roughness by 57% (Fig 5). To discard the
possibility that the difference in roughness was due to the fixation method we repeated the
roughness analysis using cells fixed for 15 minutes with 2.5% paraformaldehyde in PBS and we
obtained equivalent results (GPAT2 silencing decreased Rq by 36%).
Surface roughness analysis demonstrated measurable differences between GPAT2-silenced
and control cells, providing novel quantifiable data of cellular changes related to GPAT2
expression at the cell surface level.
Membrane integrity. High-resolution AFM imaging revealed membrane damage, visual-
ized as pore-like structures randomly distributed on the surface of sh-MDA cells (white arrows
Fig 6A). The amount of pore-like structures observed in sh-MDA cells was 0.56 ± 0.11 pore-
like structures/ μm2. We performed the section analysis of our images of sh-MDA cells and the
average pore size diameter was 270.4 ± 52.1 nm (n = 21). In none of the scr-MDA images (Fig
6A) pore-like structures were observed.
AFM has been used to study pore formation in other biological systems [19,32,33]. How-
ever, AFM technique is a single-cell assay so; to validate this result and to analyze the biological
outcome of the pore presence we quantified LDH activity in the cellular supernatants of both
cell lines. sh-MDA released 3.6-fold more LDH to the medium than scr-MDA cells (Fig 7).
LDH is a cytosolic enzyme, its presence in the culture medium indicates membrane damage
and is associated with less healthy cells [34,35]. This result correlates with our previously
reported diminished cell proliferation rate for sh-MDA cells [8].
GPAT2 expression and plasma membrane topography
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Fig 4. Optical microscopy and AFM images of scr-MDA and sh-MDA cells. AFM images were obtained in tapping topography
(A-D for scr-MDA and G-J for sh-MDA) and amplitude modes (E for scr-MDA and K for sh-MDA). Fig 4A presents topographical
parameters of a complete scr-MDA cell. Fig 4E presents amplitude image. Fig 4G presents topographical parameters of complete
sh-MDA cell, and Fig 4K presents amplitude image. Parameters of the pictures are 50.0 μm x 50.0 μm (Fig 4A, E, G and K);
30.0 μm x 30.0 μm (Fig 4B and H); 15.0 μm x 15.0 μm (Fig 4C and I); 10.0 μm x 10.0 μm (Fig 4D and J). All images have a
resolution of 512 x 512 pixels. The height of the cell is expressed in color scale (right bar). White arrows in Figs 4I and J indicate
pore-like structures. Optical images (Fig 4F and L) have a magnification of 200x.
https://doi.org/10.1371/journal.pone.0189031.g004
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GPAT2 is a cancer-testis gene (http://www.cta.lncc.br/). CTs are normally expressed in
germ line cells but they are also activated in a wide range of cancer types, where they usually
encode antigens that are immunogenic and present a potential use as biomarkers and targets
for immunotherapy. Most of the CTs’ functions have not been elucidated yet, however, it was
recently reported that they may have a role in the regulation and progression of the cell cycle,
the control of transcription, cell survival and apoptosis [36].
In a previous work, we showed that GPAT2 expression increased cell proliferation and cell
migration rate, and resistance to staurosporine-induced apoptosis [8]. All these features are
related to the normal plasma membrane functionality, and for this reason in this work we
studied for the first time the topography and membrane properties of human breast cancer-
derived cells that express GPAT2 (scr-MDA), and compared with cells with silenced GPAT2
(sh-MDA).
We chose the MDA-MB-231 because it is the cell line with the highest GPAT2 expression
[8], and we found that although GPAT2 silencing did not produce significant changes in total
lipid membrane composition, it modified parameters directly related to the plasma membrane
functionality, such as roughness and permeability.
In part, this did not surprise us because it was previously reported that cell topography
and mechanical properties can change without major alterations in total lipid composition, as
occurs in HeLa cells at different stages of the cell cycle [37].
Fig 5. Cells sub-expressing GPAT2 exhibit smoother topography. A) Ra and Rq values of scr-MDA and sh-MDA cells. B) 3D
AFM topography images of scr-MDA and sh-MDA cells at 10.0 μm x 10.0 μm showing cell surface details.
https://doi.org/10.1371/journal.pone.0189031.g005
GPAT2 expression and plasma membrane topography
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Nevertheless, our observation that cells expressing GPAT2 exhibit a rougher topography
and do not have pore-like structures compared to GPAT2 silenced cells, directly implicate
GPAT2 in the regulation of these cell-surface characteristics.
Surface roughness is an established method for quantitative surface analysis. Cellular health
can be strongly implied by plasma membrane roughness, and AFM-Rq analysis is useful for
Fig 6. Cells sub-expressing GPAT2 exhibit pore-like structures. A) Representative AFM images of three different sh-MDA and scr-MDA cells
revealed pore-like structures only on the surface of sh-MDA cells indicated with white arrows in 15.0 μm x 15.0 μm images. B and C) High-resolution
10.0 μm x 10.0 μm and 5.0 μm x 5.0 μm images, respectively, of one sh-MDA cell showing pore-like structures. D) Section analysis showing the size of
two pores along the white line shown in the Fig 6B. The dashed red and blue lines define the diameter and depth of the pores indicated with red and
blue arrows, respectively, in Fig 6B. Fig 6B is the section analysis of the cell shown in Fig 4J.
https://doi.org/10.1371/journal.pone.0189031.g006
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PLOS ONE | https://doi.org/10.1371/journal.pone.0189031 December 6, 2017 12 / 18
determining the signaling molecule effect on cells [19], gene silencing or overexpression [16],
and malignant transformation [11,38]. Several studies have shown that membrane roughness
increments correlate with tumor phenotype exacerbation [11]. In particular, for breast cancer,
it was observed that compared to benign breast MCF-10 cells, the cancerous cells MCF-7
exhibit a more disorganized filamentous cytoskeleton structure with rougher membranes [38].
In addition, in human breast cancer histological sections, surface roughness increases in accor-
dance with cancer grade [16].
In this work, we found that control cells were 2.3-fold rougher than GPAT2 silenced cells.
Thus, our roughness measurements agree with those previously reported and with our previ-
ous results showing that GPAT2 expression contributes to the tumor phenotype of MDA-MB-
231 cells [8].
Surface roughness has also been used as a tool for investigating cytoskeleton structure and
integrity [39–41]. The cytoskeleton framework is a dynamic structure mainly composed of
microfilaments, microtubules and intermediate filaments. The activities of many proteins are
deregulated in cancerous cells, and that includes the proteins involved in the dynamic reorga-
nization of the cytoskeleton, which alter cell motility, morphology, adhesion and invasion
[16]. Since the underlying cytoskeleton framework governs the cellular morphology, several
studies have shown that membrane roughness variations are induced by cytoskeleton alter-
ations. Those alterations were observed in both cytoskeleton structural and remodeling
Fig 7. GPAT2 silencing disrupts membrane integrity. Cells were grown in a 48-well microplate and LDH
activity was determined in the cellular supernatants and in total cell lysates using a commercial colorimetric
method. Results are expressed as the percentage of LDH activity in the supernatants for each cell line.
Results are the means ± SD of 3 independent experiments. (* p<0.05)
https://doi.org/10.1371/journal.pone.0189031.g007
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proteins [11,40–43], and in non-cytoskeletal-related proteins, such as SMAR 1 [16]. The
tumor suppressor protein SMAR 1 expression alters the cellular cytoskeleton, decreasing the
roughness of the cell membranes [16].
Like SMAR 1, GPAT2 is not directly related to cytoskeleton composition or remodeling.
Then, to explain the cell roughness modifications associated with GPAT2 presence, we
decided to study the expression of cytoskeleton and cytoskeleton-associated proteins in control
and sh-MDA cells. For this, we analyzed the results of a transcriptomic experiment performed
by our group in scr-MDA and sh-MDA cells using an Agilent SurePrint G3 Human Gene
Expression 8x60K v2 Microarray (S1 File). After filtering off the data for a |Log Fold Change|
>2 and a p value<0.01 we observed that, compared to the control cells, some genes encoding
for proteins involved in the regulation of cellular cytoskeleton were upregulated or downregu-
lated in cells subexpressing GPAT2 (Table 1).
These results imply that the decrease in roughness in GPAT2 subexpressing cells could be
due to the alterations in the expression of cytoskeleton and cytoskeleton remodeling proteins,
but more detailed studies will be necessary to correlate GPAT2 expression with cytoskeleton
function and remodeling.
On the other hand, the AFM resolution is able to reveal the presence of micro-irregularities
such as pore-like structures. In this sense, pore-like structures were studied at the apical mem-
brane of pancreatic acinar cells [32], in the outer mitochondrial membrane [33], and at the
rituximab induced lysis of lymphoma cells [44]. Thus, this technique has been used to study
pore presence or formation in both physiological and non-physiological conditions.
Membrane integrity is critical to cell survival and function, and a reduction in cell viabil-
ity induced by pore formation is commonly observed in pathological conditions such as
drug treated, malignant, or virally transformed cells [44]. Here, we observed that only sh-
MDA cells exhibited pore-like structures and they were not present in GPAT2 expressing
cells. We discard that pore-like structures are a consequence of the fixation procedure
because first, both cell lines were fixed and AFM scanned under the same optimal conditions,
being the pore-like structures present exclusively in sh-MDA cells; and second, only sh-
MDA cells present physiological alterations compatible with membrane damage. The sh-
MDA cells show a higher release of LDH to the medium and a lower proliferation rate, com-
pared to control cells. Moreover, the disturbance in the cytoskeleston integrity can be linked
to the formation of pores. In this sense, AFM analysis showed that the treatment of HeLa
cells with colchicine, a microtubule-depolymerazing drug, produced pores in the cell mem-
brane [42]. Therefore, these results suggest that GPAT2 silencing alters the integrity of the
cell membrane, leading to an increase in its permeability and a reduction in the cellular pro-
liferation rate previously reported.
Conclusion
AFM is a powerful tool for basic research in cancer biology and the characterization of this
disease progression. In this sense, most of the recent studies have used AFM for exploratory
Table 1. Cytoskeleton related genes upregulated or downregulated in sh-MDA cells.
Gene Symbol Name Up/down in sh-MDA Log FC sh-scr
TUBB2B tubulin beta 2B class IIb Upregulated 2.40
TPPP tubulin polymerization promoting protein Upregulated 2.28
AFAP1-L1 actin filament associated protein 1-like 1 Downregulated - 4.31
ARP-M1 actin related protein M1 Downregulated - 2.57
https://doi.org/10.1371/journal.pone.0189031.t001
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research on cancer cell morphology, cell topography and mechanical properties, or the rela-
tionship of these to cell function.
In the present work, we report for the first time the morphological differences between
cells that express or subexpress a cancer-testis gene GPAT2 in a breast cancer cellular model.
GPAT2 silencing decreases cell roughness and induces the formation of pore-like structures,
which correlates with an increment in cell membrane permeability. Cancer-testis genes have
been proposed as targets for anticancer vaccines, however, the roles of these reactivated testis
genes in supporting tumorigenic features have been less studied. Here, based on GPAT2
expression, we validated AFM as a modern and valuable tool to correlate plasma membrane
topographical alterations with malignant phenotype.
Supporting information
S1 File. Microarray transcriptomic data. scr-MDA and sh-MDA cell mRNA expression pro-
file was analyzed using an Agilent SurePrint G3 Human Gene Expression 8x60K v2 Microar-
ray.
(XLSX)
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